表紙
市場調査レポート

MediPoint: 先進創傷被覆剤 - 世界市場の分析と予測

MediPoint: Advanced Wound Dressings - Global Analysis and Market Forecasts

発行 GlobalData 商品コード 337337
出版日 ページ情報 英文 306 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
MediPoint: 先進創傷被覆剤 - 世界市場の分析と予測 MediPoint: Advanced Wound Dressings - Global Analysis and Market Forecasts
出版日: 2015年05月12日 ページ情報: 英文 306 Pages
概要

先進創傷被覆剤は、火傷、切り傷、裂傷および擦り傷といった急性創傷や、糖尿病性足潰瘍、褥瘡および手術創傷といった慢性創傷の様々な治療に用いられます。先進被覆剤は、創傷ケア産業の安定して成長しているセグメントであり、多くの企業が多種多様なフォーマットを市販しています。

当レポートでは、世界の主要10ヶ国における先進創傷被覆剤市場ついて分析し、産業の概要、主要10ヶ国の市場展望、パイプライン分析、および現在・将来の競合情勢の分析などを提供しています。

第1章 目次

第2章 イントロダクション

第3章 産業概要

  • 概要
  • 解剖学・生理学
  • 症状
  • 臨床転帰
  • 技術の用途
  • 技術のメリット・デメリット
  • 市場アクセス
  • 規制プロセス
  • 医療費償還
  • 産業動向
  • 経済的な影響

第4章 アンメットニーズ

  • 概要
  • 最適な抗菌力
  • 生物活性被覆剤の強化
  • 傷口の外傷・痛みの最小化
  • マルチモーダル被覆剤の設計
  • 指標の進歩・診断力の改善
  • 教育・認識の拡大

第5章 市場機会の分析

  • 概要
  • 陰圧閉鎖療法 (NPWT) の補完
  • 圧迫療法向け被覆剤のエンジニアリング
  • 腫瘍の放射線熱傷への対応
  • 瘢痕管理の進歩
  • 局所ドラッグデリバリーの実行

第6章 市場成長促進因子・障壁

  • 促進因子
  • 障壁

第7章 競合評価

  • 概要
  • 技術・提供製品
  • 製品プロファイル
  • 各分類向けのSWOT

第8章 パイプライン評価

  • 概要
  • 製品プロファイル

第9章 注目の臨床試験

  • 概要
  • 臨床試験プロファイル

第10章 現在の企業・将来の企業

  • 概要
  • 企業戦略における動向
  • 企業プロファイル

第11章 戦略的競合評価

  • 企業の市場シェア

第12章 市場展望:市場区分

  • 市場区分のシェア

第13章 市場展望:地域別

  • 世界の概要
  • 米国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
  • 日本
  • 中国
  • インド
  • ブラジル

第14章 付録

図表リスト

目次
Product Code: GDME0212MAR

Advanced wound dressings are used to treat a variety of acute wounds, such as burns, cuts, lacerations and abrasions, chronic wounds, such as a diabetic foot ulcers, pressure ulcers and leg ulcers, and surgical wounds sustained during various procedures.

Advanced dressings are a steadily growing segment of the wound care industry, with many companies marketing a wide variety of formats. Emerging markets are expected to demonstrate the highest growth among the 10 major markets (10MM) covered in the report, including the US, France, Germany, Italy, Spain, UK, Japan, China, India and Brazil.

The major segments of advanced wound dressings are foams, alginates, hydrocolloids, hydrofibers, collagens, hydrogels, semi-permeable films, superabsorbents and wound contact layers.

The advanced dressings market will be strongly driven by increasing prevalence of chronic wounds worldwide because rates of risk factors, such as diabetes, obesity and cardiovascular disease, continue to rise.

The global advanced dressings market is largely dominated by the key players such as Smith & Nephew, 3M, Molnlycke, ConvaTec and Coloplast. Smaller manufacturers such as Paul Hartmann, Acelity and Urgo also play an important role in the market.

Unmet needs will future innovation in the development of smart dressings and wound diagnostics.

Key Opinion Leaders emphasize the rise of chronic wounds and associated risk factors as an incentive for the development of better wound care. Furthermore, they highlight technological limitations of certain advanced dressing formats and enumerate unmet needs, such as the need for better clinical evidence.

Highlights

Key Questions Answered

  • What is the current and future advanced wound dressings market outlook in the developed and emerging markets? What trends are affecting the global market?
  • Which are the key, high growth markets that dressings manufacturers should expand into? Which markets segments are growing the fastest?
  • What are the unmet needs with advanced dressings currently on the market? How will emerging technologies such as wound diagnostics and smart dressings fulfill these unmet needs?
  • What clinical factors affect a physician to use one type of dressing over another? What are the physician perception s and market outlooks of advanced dressings?
  • What are the challenges that have hindered widespread adoption?
  • How will emerging trends and changing market landscapes affect the future of advanced dressings?

Key Findings

  • Emerging economies are seeing the highest growth in the global advanced wound dressings market.
  • Established dressing formats, such as foams, are widely adopted, but hydrofibers, wound contact layers and superabsorbents are the fastest rising segments as key factors including better exudate management and pain mitigation become more important.
  • The most proactive wound care firms are providing comprehensive portfolios, undertaking key M&A's, fostering innovation, and focusing wisely on emerging markets to stay competitive.
  • Rising rates of risk factors to acquiring chronic wounds are the primary drivers of the wound care market. Despite respectable adoption of advanced dressings, unmet needs and non-clinical barriers remain a challenge.

Scope

  • Overview of wound indications, key factors, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
  • Annualized total advanced dressings market revenue by type of dressings and market outlooks by country through 2021.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
  • Pipeline analysis: Emerging products and technologies, including novel collagen scaffolds and biomaterial platforms.
  • Analysis of the current and future market competition in the global advanced dressings market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global advanced wound dressings market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global advanced dressings market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific advanced dressings market from 2011-2020.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview
  • 3.2. Anatomy & Physiology
  • 3.3. Indications
    • 3.3.1. Acute Wounds
    • 3.3.2. Chronic Wounds
    • 3.3.3. Surgical Wounds
  • 3.4. Clinical Outcomes
    • 3.4.1. Normal Wound Healing Process
    • 3.4.2. Key Factors to Wound Management
  • 3.5. Applications of Technology
    • 3.5.1. Traditional Wound Care Products
    • 3.5.2. Current Advanced Wound Dressing Modalities
    • 3.5.3. Biologics & Tissue-Engineered Products
    • 3.5.4. Device and Equipment Therapies
  • 3.6. Advantages and Disadvantages of Technology
  • 3.7. Market Access
    • 3.7.1. Overview
    • 3.7.2. Adoption of Technology
    • 3.7.3. Brand Loyalty and Relationships with Manufacturers
    • 3.7.4. Purchasing Decisions
    • 3.7.5. Influence of Clinical Trials
  • 3.8. Regulatory Process
    • 3.8.1. Overview
    • 3.8.2. United States
    • 3.8.3. Europe
    • 3.8.4. Japan
    • 3.8.5. China
    • 3.8.6. India
    • 3.8.7. Brazil
  • 3.9. Reimbursement
    • 3.9.1. Overview
    • 3.9.2. United States
    • 3.9.3. France
    • 3.9.4. Germany
    • 3.9.5. Italy
    • 3.9.6. Spain
    • 3.9.7. United Kingdom
    • 3.9.8. Japan
    • 3.9.9. China
    • 3.9.10. India
    • 3.9.11. Brazil
  • 3.10. Industry Trends
    • 3.10.1. Regulatory Issues & Recalls
    • 3.10.2. Mergers, Acquisitions, and Key Partnerships
  • 3.11. Economic Impact
    • 3.11.1. Indirect Costs
    • 3.11.2. Direct Costs

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Optimal Antimicrobial Power
  • 4.3. Enhancing Biologically Active Dressings
  • 4.4. Minimizing Trauma and Pain at Wound Sites
  • 4.5. Designing Multimodal Dressings
  • 4.6. Advancing Indicators and Improving Diagnostic Power
  • 4.7. Expanding Education and Awareness

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Complementing Negative Pressure Wound Therapy
  • 5.3. Engineering Dressings for Compression Therapy
  • 5.4. Addressing Radiation Oncology Burns
  • 5.5. Progressing Scar Management
  • 5.6. Implementing Topical Drug Delivery

6. Market Drivers and Barriers

  • 6.1. Drivers
    • 6.1.1. Occurrence of Burns
    • 6.1.2. Rising Rates of Diabetes
    • 6.1.3. Aging Population
    • 6.1.4. Rising Rates of Vascular Diseases
    • 6.1.5. Rising Rates of Obesity
    • 6.1.6. Need for Cost Savings
  • 6.2. Barriers
    • 6.2.1. Diminished Role of Advanced Dressings in Standard Therapies
    • 6.2.2. Lack of Reimbursements
    • 6.2.3. Complexities in Healthcare Systems
    • 6.2.4. Regulatory Challenges
    • 6.2.5. Lack of Clinical Data
    • 6.2.6. Medical Device Excise Tax
    • 6.2.7. Availability of Venture Capital

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Technology and Product Offerings
  • 7.3. Product Profiles
    • 7.3.1. Smith & Nephew
    • 7.3.2. 3M Health Care
    • 7.3.3. Molnlycke Health Care
    • 7.3.4. ConvaTec
    • 7.3.5. Coloplast
    • 7.3.6. Paul Hartmann
    • 7.3.7. Systagenix Wound Management
    • 7.3.8. Medline Industries
    • 7.3.9. Laboratoires Urgo
    • 7.3.10. BSN Medical
    • 7.3.11. Covidien
    • 7.3.12. B. Braun
    • 7.3.13. Hollister
    • 7.3.14. Derma Sciences
    • 7.3.15. Lohmann & Rauscher
    • 7.3.16. Advanced Medical Solutions
    • 7.3.17. Nitto Denko
    • 7.3.18. Winner Medical Group
    • 7.3.19. DeRoyal Industries
    • 7.3.20. Genewel
  • 7.4. SWOT For Each Category
    • 7.4.1. SWOT, Foams
    • 7.4.2. SWOT, Hydrocolloids
    • 7.4.3. SWOT, Semi-Permeable Films
    • 7.4.4. SWOT, Hydrogels
    • 7.4.5. SWOT, Alginates
    • 7.4.6. SWOT, Hydrofibers
    • 7.4.7. SWOT, Collagens
    • 7.4.8. SWOT, Superabsorbents
    • 7.4.9. SWOT, Wound Contact Layers

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Product Profiles
    • 8.2.1. MxBiodevices: Dermagrid
    • 8.2.2. PolyNovo: NovoSorb BTM
    • 8.2.3. Tissue Therapies: VitroGro ECM
    • 8.2.4. Edixomed: ProNOx
    • 8.2.5. KeraNetics: KeraStat
    • 8.2.6. Arteriocyte: Magellan Bio-Bandage
    • 8.2.7. Nanotherapeutics: NanoDOX
    • 8.2.8. DeCell Technologies: DermGEN
    • 8.2.9. Eqalix: OmegaSkin

9. Clinical Trials to Watch

  • 9.1. Overview
  • 9.2. Clinical Trial Profiles
    • 9.2.1. Adocia
    • 9.2.2. DermaPACE
    • 9.2.3. Amnioexcel and DSC127
    • 9.2.4. TransCu O2
    • 9.2.5. Woundchek

10. Current and Future Players

  • 10.1. Overview
  • 10.2. Trends in Corporate Strategy
  • 10.3. Company Profiles
    • 10.3.1. Smith & Nephew
    • 10.3.2. 3M Health Care
    • 10.3.3. Molnlycke Health Care
    • 10.3.4. ConvaTec
    • 10.3.5. Coloplast
    • 10.3.6. Paul Hartmann
    • 10.3.7. Systagenix Wound Management
    • 10.3.8. Medline Industries
    • 10.3.9. Laboratoires Urgo
    • 10.3.10. BSN Medical
    • 10.3.11. Covidien
    • 10.3.12. B. Braun
    • 10.3.13. Hollister
    • 10.3.14. Derma Sciences
    • 10.3.15. Lohmann & Rauscher
    • 10.3.16. Advanced Medical Solutions Group
    • 10.3.17. Nitto Denko
    • 10.3.18. Winner Medical Group
    • 10.3.19. Genewel
    • 10.3.20. DeRoyal Industries

11. Strategic Competitive Assessment

  • 11.1. Company Market Share
    • 11.1.1. Global Overview
    • 11.1.2. Company Share by Region
    • 11.1.3. Company Share by Individual Country

12. Market Outlooks by Market Segment

  • 12.1. Market Segment Share
    • 12.1.1. Global
    • 12.1.2. By Region

13. Market Outlooks by Geography

  • 13.1. Global Overview
  • 13.2. US
  • 13.3. France
  • 13.4. Germany
  • 13.5. Italy
  • 13.6. Spain
  • 13.7. UK
  • 13.8. Japan
  • 13.9. China
  • 13.10. India
  • 13.11. Brazil

14. Appendix

  • 14.1. Bibliography
  • 14.2. Abbreviations
  • 14.3. Report Methodology
    • 14.3.1. Overview
    • 14.3.2. Coverage
    • 14.3.3. Secondary Research
  • 14.4. Forecasting Methodology
  • 14.5. Physicians and Specialists Included in This Study
    • 14.5.1. Key Opinion Leaders
    • 14.5.2. Primary Research Summary
  • 14.6. About the Authors
    • 14.6.2. Global Head of Healthcare
  • 14.7. About GlobalData
  • 14.8. Disclaimer

List of Tables

  • Table 1: Types of Burns: Characteristics and Treatment Options
  • Table 2: Stages of Pressure Ulcers
  • Table 3: Types of Surgical Wounds
  • Table 4: Sample HCPCS Codes for Advanced Wound Dressings
  • Table 5: ICD-9 Coding Guide for Chronic and Acute Wounds
  • Table 6: Reimbursement Classification for Medical Devices in Japan
  • Table 7: Smith & Nephew Advanced Wound Dressings Marketed Products
  • Table 8: Smith & Nephew Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015
  • Table 9: 3M Advanced Wound Dressings Marketed Products
  • Table 10: 3M Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 11: Molnlycke Advanced Wound Dressings Marketed Products
  • Table 12: Molnlycke Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 13: ConvaTec Advanced Wound Dressings Marketed Products
  • Table 14: ConvaTec Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 15: Coloplast Advanced Wound Dressings Marketed Products
  • Table 16: Coloplast Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 17: Paul Hartmann Advanced Wound Dressings Marketed Products
  • Table 18: Paul Hartmann Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 19: Systagenix Advanced Wound Dressings Marketed Products
  • Table 20: Systagenix Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 21: Medline Industries Advanced Wound Dressings Marketed Products
  • Table 22: Medline Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 23: Laboratoires Urgo Advanced Wound Dressings Marketed Products
  • Table 24: Urgo Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 25: BSN Medical Advanced Wound Dressings Marketed Products
  • Table 26: BSN Medical Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015
  • Table 27: Covidien Advanced Wound Dressings Marketed Products
  • Table 28: Covidien Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 29: B. Braun Advanced Wound Dressings Marketed Products
  • Table 30: B. Braun Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 31: Hollister Advanced Wound Dressings Marketed Products
  • Table 32: Hollister Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 33: Derma Sciences Advanced Wound Dressings Marketed Products
  • Table 34: Derma Sciences Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 35: Lohmann & Rauscher Advanced Wound Dressings Marketed Products
  • Table 36: Lohmann & Rauscher Advanced Wound Dressings Product Portfolio, SWOT Analysis, 2015
  • Table 37: Advanced Medical Solutions Advanced Wound Dressings Marketed Products
  • Table 38: Advanced Medical Solutions Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015
  • Table 39: Nitto Denko Advanced Wound Dressings Marketed Products
  • Table 40: Winner Medical Group Advanced Wound Dressings Marketed Products
  • Table 41: DeRoyal Industries Advanced Wound Dressings Marketed Products
  • Table 42: DeRoyal Industries Advanced Wound Dressings Product Portfolio SWOT Analysis, 2015
  • Table 43: Genewel Advanced Wound Dressings Marketed Products
  • Table 44: Foams SWOT Analysis, 2015
  • Table 45: Hydrocolloids SWOT Analysis, 2015
  • Table 46: Semi-Permeable Films SWOT Analysis, 2015
  • Table 47: Hydrogels SWOT Analysis, 2015
  • Table 48: Alginates SWOT Analysis, 2015
  • Table 49: Hydrofibers SWOT Analysis, 2015
  • Table 50: Collagens SWOT Analysis, 2015
  • Table 51: Superabsorbents SWOT Analysis, 2015
  • Table 52: Wound Contact Layers SWOT Analysis, 2015
  • Table 53: Dermagrid SWOT Analysis, 2015
  • Table 54: NovoSorb BTM SWOT Analysis, 2015
  • Table 55: VitroGro SWOT Analysis, 2015
  • Table 56: ProNOx SWOT Analysis, 2015
  • Table 57: KeraStat SWOT Analysis, 2015
  • Table 58: Magellan Bio-Bandage SWOT Analysis, 2015
  • Table 59: nanoDOX SWOT Analysis, 2015
  • Table 60: DermGEN SWOT Analysis, 2015
  • Table 61: OmegaSkin SWOT Analysis, 2015
  • Table 62: Smith & Nephew Company Profile
  • Table 63: Smith & Nephew SWOT Analysis, 2015
  • Table 64: 3M Company Profile
  • Table 65: 3M SWOT Analysis, 2015
  • Table 66: Molnlycke Company Profile
  • Table 67: Molnlycke SWOT Analysis, 2015
  • Table 68: ConvaTec Company Profile
  • Table 69: ConvaTec SWOT Analysis, 2015
  • Table 70: Coloplast Company Profile
  • Table 71: Coloplast SWOT Analysis, 2015
  • Table 72: Paul Hartmann Company Profile
  • Table 73: Paul Hartmann SWOT Analysis, 2015
  • Table 74: Systagenix Company Profile
  • Table 75: Systagenix SWOT Analysis, 2015
  • Table 76: Medline Company Profile
  • Table 77: Medline SWOT Analysis, 2015
  • Table 78: Laboratoires Urgo Company Profile
  • Table 79: Laboratoires Urgo SWOT Analysis, 2015
  • Table 80: BSN Medical Company Profile
  • Table 81: BSN Medical SWOT Analysis, 2015
  • Table 82: Covidien Company Profile
  • Table 83: Covidien SWOT Analysis, 2015
  • Table 84: B. Braun Company Profile
  • Table 85: B. Braun SWOT Analysis, 2015
  • Table 86: Hollister Company Profile
  • Table 87: Hollister SWOT Analysis, 2015
  • Table 88: Derma Sciences Company Profile
  • Table 89: Derma Sciences SWOT Analysis, 2015
  • Table 90: Lohmann & Rauscher Company Profile
  • Table 91: Lohmann & Rauscher SWOT Analysis, 2015
  • Table 92: Advanced Medical Solutions Company Profile
  • Table 93: Advanced Medical Solutions SWOT Analysis, 2015
  • Table 94: Nitto Denko Company Profile
  • Table 95: Nitto Denko SWOT Analysis, 2015
  • Table 96: Winner Medical Group Company Profile
  • Table 97: Winner Medical Group SWOT Analysis, 2015
  • Table 98: Genewel SWOT Analysis, 2015
  • Table 99: DeRoyal Industries Company Profile
  • Table 100: DeRoyal SWOT Analysis, 2015
  • Table 101: Global Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 102: 5EU Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 103: APAC Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 104: Total Sales Volume by Country for Advanced Wound Dressings, in number of units sold, 2011-2021
  • Table 105: Global Market Value Forecast by Country for Advanced Wound Dressings, $m, 2011-2021
  • Table 106: US Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 107: France Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 108: Germany Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 109: Italy Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 110: Spain Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 111: UK Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 112: Japan Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 113: China Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 114: India Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021
  • Table 115: Brazil Market Value Forecast by Market Segment for Advanced Wound Dressings, $m, 2011-2021

List of Figures

  • Figure 1: Usage Frequency of Antimicrobials
  • Figure 2: Influences on Product Adoption
  • Figure 3: Frequency of Advanced Dressing Usage Based on Brand
  • Figure 4: Influencers of Purchasing Decisions
  • Figure 5: Reimbursement Perceptions
  • Figure 6: Unmet Needs
  • Figure 7: Global Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 8: 5EU Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 9: APAC Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 10: US Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 11: France Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 12: Germany Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 13: Italy Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 14: Spain Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 15: United Kingdom Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 16: Japan Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 17: China Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 18: India Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 19: Brazil Company Market Shares for Advanced Wound Dressings, 2013
  • Figure 20: Global Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011-2021
  • Figure 21: 5EU Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011-2021
  • Figure 22: APAC Market Value Forecast by Market Segment for Advanced Wound Dressings, 2011-2021
  • Figure 23: Global Sales Volume for Advanced Wound Dressings, Number of Units, 2011-2021
  • Figure 24: Global Market Value Forecast by Country, $m, 2011-2021
  • Figure 25: Global Market Share Comparison by Country, 2014 & 2021
  • Figure 26: 5EU Market Share Comparison by Country, 2014 & 2021
  • Figure 27: APAC Market Share Comparison by Country, 2014 & 2021
  • Figure 28: US Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 29: US Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 30: France Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 31: France Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 32: Germany Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 33: Germany Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 34: Italy Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 35: Italy Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 36: Spain Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 37: Spain Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 38: UK Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 39: UK Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 40: Japan Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 41: Japan Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 42: China Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 43: China Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 44: India Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 45: India Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 46: Brazil Market Value Forecast by Market Segment, $m, 2011-2021
  • Figure 47: Brazil Market Value Comparison by Market Segment, 2014 & 2021
  • Figure 48: Primary Research Participants By Country
Back to Top